SCI(E) Original Articles - First Author or Corresponding Author

1. Moon Y, Park JK, Lee KY, Namkoong M, Ahn S. Consolidation/Tumor Ratio on Chest Computed Tomography as Predictor of Postoperative Nodal Upstaging in Clinical T1N0 Lung Cancer. (World J Surg. 2018 Feb 15. doi: 10.1007/s00268-018-4543-8. [Epub ahead of print])

2. Moon Y, Lee KY, Park JK, The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection. ( Thorac Dis. 2017 Oct;9(10):3782-3792)

3. Moon Y, Lee KY, Park JK., Margin Width of Resected Lepidic Lung Cancer Does Not Affect Recurrence After Sublobar Resection. (World J Surg. 2017 Oct 17. doi: 10.1007/s00268-017-4291-1. [Epub ahead of print]

4. Moon Y, Lee KY, Park JK., Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion. (World J Surg. 2017 Jun 8. doi: 10.1007/s00268-017-4075-7. [Epub ahead of print])

5. Moon Y, Park JK, Lee KY, Sung SW. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3cm or less (Respirology. 2017 Aug;22(6):1179-1184)

6. Moon Y, Lee KY, Moon SW, Park JK. Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non-small Cell Lung Cancer Presenting as GGO-Predominant Nodule of 3 cm or Less. (World J Surg. 2017 Feb;41(2):472-479)

7. Moon Y, Sung SW, Lee KY, Park JK. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule. (J Thorac Dis. 2016 Sep;8(9):2562-2570)

8. Moon Y, Sung SW, Namkoong M, Park JK. The effectiveness of mediastinal lymph node evaluation in a patient with ground glass opacity tumor. (J Thorac Dis. 2016 Sep;8(9):2617-2625)

9. Moon Y, Sung SW, Moon SW, Park JK. Risk factors for recurrence after sublobar resection in patients with small (2 cm or less) non-small cell lung cancer presenting as a solid-predominant tumor on chest computed tomography. (J Thorac Dis. 2016 Aug;8(8):2018-26)

10. Moon Y, Sung SW, Lee KY, Sim SB, Park JK. Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma. (J Thorac Dis. 2016 Jul;8(7):1561-70)

11. Moon Y, Kim KS, Lee KY, Sung SW, Kim YK, Park JK. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma. (Ann Thorac Surg. 2016 May;101(5):1928-35)

12. Moon Y, Sung SW, Lee KY, Kim YK, Park JK. The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma. (World J Surg Oncol. 2016 Feb 16;14(1):37)

13. Moon Y, Lee KY, Sung SW, Park JK. Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations. (J Thorac Dis. 2016 Jan;8(1):169-77)

14. Moon Y, Lee KY, Kim KS, Park JK. Clinicopathologic correlates of postoperative N1 or N2 nodal upstaging in non-small cell lung cancer. (J Thorac Dis. 2016 Jan;8(1):79-85)

15. Moon Y, Kim KS, Park JK. Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion. (J Cardiothorac Surg. 2015 Oct 28;10:136)

16. Moon Y, Park JK, Sung SW. Surgery for localized pulmonary mycotic infections in patients with hematopoietic disorder. (J Cardiothorac Surg. 2015 Jun 30;10:91)

17. Moon Y, Kim KS, Sung SW, Lee KY, Kim YK, Kang JH, Kim YS, Park JK. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma. (World J Surg Oncol. 2014 Dec 17;12:388)